Zhao‐you Tang
#149,368
Most Influential Person Now
Zhao‐you Tang's AcademicInfluence.com Rankings
Zhao‐you Tangphilosophy Degrees
Philosophy
#8194
World Rank
#11527
Historical Rank
Logic
#5221
World Rank
#6604
Historical Rank

Download Badge
Philosophy
Zhao‐you Tang's Degrees
- PhD Medicine Fudan University
Why Is Zhao‐you Tang Influential?
(Suggest an Edit or Addition)Zhao‐you Tang's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Randomized controlled trial of screening for hepatocellular carcinoma (2004) (1296)
- EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. (2009) (1092)
- Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. (2007) (1047)
- Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning (2003) (816)
- Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. (2006) (782)
- A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. (2010) (755)
- Identification of metastasis‐related microRNAs in hepatocellular carcinoma (2008) (726)
- EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. (2008) (687)
- MicroRNA expression, survival, and response to interferon in liver cancer. (2009) (643)
- Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. (2011) (546)
- Identification of microRNA‐181 by genome‐wide screening as a critical player in EpCAM–positive hepatic cancer stem cells (2009) (530)
- High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. (2008) (505)
- p53 mutation in hepatocellular carcinoma after aflatoxin exposure (1991) (478)
- A decade’s studies on metastasis of hepatocellular carcinoma (2004) (426)
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects (2010) (321)
- The prognostic molecular markers in hepatocellular carcinoma. (2002) (319)
- Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. (2012) (290)
- Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma (2001) (280)
- Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics (2004) (210)
- Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma (2007) (210)
- Transcriptomic profiling reveals hepatic stem‐like gene signatures and interplay of miR‐200c and epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma (2012) (206)
- Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature (2004) (204)
- Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. (2010) (201)
- Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. (2013) (184)
- Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial (2006) (183)
- Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma (2017) (180)
- Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells (2009) (180)
- Heat‐shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis (2005) (176)
- The prognostic significance of clinical and pathological features in hepatocellular carcinoma. (2002) (172)
- From Proteomic Analysis to Clinical Significance (2004) (167)
- Clinical evaluation of cryosurgery in the treatment of primary liver cancer Report of 60 Cases (1988) (166)
- A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. (2005) (166)
- Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. (2007) (163)
- Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. (2006) (163)
- Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues (1996) (160)
- Proteome analysis of hepatocellular carcinoma cell strains, MHCC97‐H and MHCC97‐L, with different metastasis potentials (2004) (150)
- Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma (2008) (145)
- GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis. (2016) (144)
- Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. (2006) (143)
- Activation of β-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis (2010) (142)
- miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a (2018) (139)
- The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis. (2008) (139)
- Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative Resection (2008) (139)
- Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3 (2006) (138)
- Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition (2011) (133)
- Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study (2018) (131)
- Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. (2009) (129)
- Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. (2011) (125)
- High‐lose and long‐term therapy with interferon‐alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential (2000) (122)
- Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. (2003) (120)
- Hepatocellular carcinoma: insight from animal models (2012) (111)
- Microvessel density of hepatocellular carcinoma: its relationship with prognosis (1999) (110)
- Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma (2013) (109)
- Wnt signaling in hepatocellular carcinoma: Analysis of mutation and expression of beta‐catenin, T‐cell factor‐4 and glycogen synthase kinase 3‐beta genes (2003) (107)
- MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2 (2016) (107)
- Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy (2009) (106)
- MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression. (2013) (104)
- MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2α/Akt/HIF-1α Pathway in Hepatocellular Carcinoma (2013) (101)
- Dendritic cell infiltration and prognosis of human hepatocellular carcinoma (2006) (100)
- Gene Expression Profiling of Fixed Tissues Identified Hypoxia-Inducible Factor-1α, VEGF, and Matrix Metalloproteinase-2 as Biomarkers of Lymph Node Metastasis in Hepatocellular Carcinoma (2011) (100)
- Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival (2009) (97)
- Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives (2004) (92)
- A Comparison of Chemoembolization Combination With and Without Radiotherapy for Unresectable Hepatocellular Carcinoma (2004) (92)
- The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma (2006) (89)
- Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study. (2004) (87)
- HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection (2012) (86)
- The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma (2013) (86)
- Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients. (2005) (85)
- Diagnosis and treatment of hepatic angiomyolipoma in 26 cases. (2003) (85)
- Overexpression of Platelet-Derived Growth Factor Receptor α in Endothelial Cells of Hepatocellular Carcinoma Associated with High Metastatic Potential (2005) (84)
- Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy (2007) (84)
- Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice. (2012) (81)
- Modulation of miR‐29 expression by alpha‐fetoprotein is linked to the hepatocellular carcinoma epigenome (2014) (78)
- Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma (2009) (78)
- High expression of Dickkopf‐related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery (2013) (78)
- Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus (2000) (75)
- Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1 (1999) (75)
- Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor (2008) (74)
- Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice (2003) (72)
- Hepatocellular carcinoma surgery–review of the past and prospects for the 21st century (2005) (71)
- The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs) (2012) (70)
- Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma. (2017) (70)
- Consideration of the Role of Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Retrospective Analysis of 75 Patients (2006) (69)
- MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells (2014) (69)
- The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma (2006) (69)
- Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection (2014) (67)
- Elevated activity of N -acetylglucosaminyltransferase V in human hepatocellular carcinoma (1998) (66)
- Combination of peritumoral mast cells and T‐regulatory cells predicts prognosis of hepatocellular carcinoma (2009) (66)
- Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. (2005) (65)
- Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients (2010) (65)
- Radiation therapy for adrenal gland metastases from hepatocellular carcinoma. (2005) (65)
- Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience. (2006) (64)
- Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation (2009) (63)
- Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. (2008) (63)
- Improved Survival with Resectionafter Transcatheter ArterialChemoembolization (TACE) for Unresectable Hepatocellular Carcinoma (1998) (62)
- Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues (2006) (62)
- Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma: A Single Center Study of 45 Patients. (2020) (61)
- Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer (2013) (60)
- P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection. (2002) (60)
- Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations (2021) (58)
- High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection. (2010) (58)
- Interferon alpha 2a downregulates VEGF expression through PI3 kinase and MAP kinase signaling pathways (2005) (57)
- Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure. (2008) (56)
- Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials. (2003) (55)
- Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating β-Catenin Signaling (2014) (54)
- Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma (2009) (53)
- Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin (2010) (52)
- Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma (2013) (52)
- Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma (2001) (52)
- Identification and analysis of altered α1,6‐fucosylated glycoproteins associated with hepatocellular carcinoma metastasis (2006) (52)
- Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma (2019) (51)
- Increased Expression of Vascular Endothelial Growth Factor-C and Nuclear CXCR4 in Hepatocellular Carcinoma Is Correlated With Lymph Node Metastasis and Poor Outcome (2009) (51)
- CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma (2019) (51)
- P48 is a predictive marker for outcome of postoperative interferon‐α treatment in patients with hepatitis B virus infection‐related hepatocellular carcinoma (2006) (51)
- Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients. (2004) (50)
- Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma (2007) (50)
- Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: Relevance of epithelial–mesenchymal transition (2010) (50)
- Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion. (2007) (48)
- Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection (2010) (48)
- Integrative Genomics Identifies YY1AP1 as an Oncogenic Driver in EpCAM+ AFP+ Hepatocellular Carcinoma (2014) (47)
- Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients. (2006) (47)
- Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external‐beam radiation therapy (2008) (46)
- Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis (2003) (45)
- Surgery for large primary liver cancer more than 10 cm in diameter (2003) (45)
- Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential (2005) (44)
- Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization (2012) (44)
- First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study. (2013) (43)
- Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model (2014) (42)
- The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome (2012) (42)
- Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases (2010) (42)
- Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating HTATIP2 in Hepatocellular Carcinoma (2013) (41)
- Experimental models of hepatocellular carcinoma: developments and evolution (2009) (41)
- Risk factors for postoperative complications after liver resection. (2005) (40)
- A comparison of hepatic mucinous cystic neoplasms with biliary intraductal papillary neoplasms. (2009) (40)
- Targeting angiogenesis for liver cancer: Past, present, and future (2020) (40)
- Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma. (2011) (39)
- Focal nodular hyperplasia of the liver in 86 patients. (2007) (39)
- Hepatic angiomyolipoma: A retrospective study of 25 cases (2008) (39)
- Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway. (2017) (38)
- From Proteomic Analysis to Clinical Significance OVEREXPRESSION OF CYTOKERATIN 19 CORRELATES WITH HEPATOCELLULAR CARCINOMA METASTASIS* (2004) (38)
- Clinical Experience with Primary Hepatic Epithelioid Hemangioendothelioma: Retrospective Study of 33 Patients (2012) (38)
- Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice (2008) (37)
- Low Level of Low-Density Lipoprotein Receptor-Related Protein 1 Predicts an Unfavorable Prognosis of Hepatocellular Carcinoma after Curative Resection (2012) (37)
- Integrative Genomic and Transcriptomic Characterization of Matched Primary and Metastatic Liver and Colorectal Carcinoma (2015) (37)
- Expression of the integrinα5 subunit and its mediated cell adhesion in hepatocellular carcinoma (2005) (37)
- Iodized oil enhances the thermal effect of high-intensity focused ultrasound on ablating experimental liver cancer (1997) (36)
- Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second‐look resection (1990) (36)
- Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma (2011) (36)
- Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins (2004) (35)
- Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification (2007) (34)
- An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma (2011) (34)
- Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma (2012) (34)
- Identification of N-glycan of alpha-fetoprotein by lectin affinity microarray (2008) (34)
- Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential. (2012) (34)
- Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume. (2010) (33)
- Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue (2011) (33)
- The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma (1998) (32)
- Herbal extract “Songyou Yin” inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential (2009) (32)
- Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival (2009) (31)
- Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI‐D20) with high metastasis potential (2006) (31)
- Mutation and overexpression of the β-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people (2001) (30)
- High-intensity focused ultrasound in the treatment of experimental liver tumour (2005) (30)
- The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases (2005) (29)
- Insufficient Radiofrequency Ablation Treated Hepatocellular Carcinoma Cells Promote Metastasis by Up-Regulation ITGB3 (2017) (28)
- Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models (2013) (28)
- Cytoreduction and sequential resection: A hope for unresectable primary liver cancer (1991) (28)
- Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma. (2000) (28)
- Truncated Hepatitis B Virus RNA in Human Hepatocellular Carcinoma: Its Representation in Patients with Advancing Age (1999) (28)
- A three-dimensional cell biology model of human hepatocellular carcinoma in vitro (2011) (27)
- Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma. (2004) (27)
- Preliminary result of mixed bacterial vaccine as adjuvant treatment of hepatocellular carcinoma (1991) (27)
- Flot2 promotes tumor growth and metastasis through modulating cell cycle and inducing epithelial-mesenchymal transition of hepatocellular carcinoma. (2017) (26)
- Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: Evaluation with analysis of 72 patients (1995) (26)
- Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma (2013) (26)
- Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma (2002) (26)
- Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. (2006) (26)
- Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma (2011) (25)
- Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb. Phase I/II clinical trials (1998) (25)
- Prognostic Roles of Cross-Talk between Peritumoral Hepatocytes and Stromal Cells in Hepatocellular Carcinoma Involving Peritumoral VEGF-C, VEGFR-1 and VEGFR-3 (2013) (25)
- Loss of Heterozygosity at D8S298 Is a Predictor for Long-term Survival of Patients with Tumor-Node-Metastasis Stage I of Hepatocellular Carcinoma (2007) (25)
- A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice (2011) (25)
- Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography (2011) (25)
- Relationship between expression of α-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma (1999) (24)
- Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells. (2010) (24)
- Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients (2006) (24)
- A novel peptide that selectively binds highly metastatic hepatocellular carcinoma cell surface is related to invasion and metastasis. (2007) (24)
- Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma (2016) (24)
- PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma (2021) (24)
- MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma (2016) (23)
- Abdominal drainage was unnecessary after hepatectomy using the conventional clamp crushing technique (2006) (23)
- The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background (2005) (23)
- A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma (2015) (23)
- Transmembrane receptor CXCR7 increases the risk of extrahepatic metastasis of relatively well-differentiated hepatocellular carcinoma through upregulation of osteopontin. (2013) (23)
- Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma (2012) (22)
- Intrahepatic splenosis mimicking hepatoma (2009) (22)
- Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines. (2003) (21)
- Metadherin–PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT–β-catenin signaling pathway (2019) (21)
- Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma (2005) (21)
- Study of angiogenesis induced by metastatic and non-metastatic liver cancer by corneal micropocket model in nude mice. (1999) (20)
- NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma (2020) (20)
- Metastatic models of human liver cancer in nude mice orthotopically constructed by using histologically intact patient specimens (2005) (20)
- [Influence of tumor characteristics on the outcome of liver transplantation among patients with hepatocellular carcinoma]. (2007) (19)
- The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target (2018) (19)
- The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib (2014) (19)
- MAGE-1 and related MAGE gene expression may be associated with hepatocellular carcinoma (1999) (19)
- Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection (2011) (19)
- Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor. (2003) (19)
- Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma (2008) (19)
- Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice (2011) (18)
- Molecular cytogenetic characteristics of the human hepatocellular carcinoma cell line HCCLM3 with high metastatic potential: comparative genomic hybridization and multiplex fluorescence in situ hybridization. (2005) (18)
- Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials (2003) (18)
- [Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria]. (2006) (18)
- Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China. (2005) (18)
- Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma (2016) (17)
- Small hepatocellular carcinoma: current status and prospects. (2002) (17)
- Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection (2017) (17)
- KIAA0008 gene is associated with invasive phenotype of human hepatocellular carcinoma—a functional analysis (2004) (17)
- Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trial. (2004) (17)
- Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis. (2008) (17)
- Abstract 5183: Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome (2014) (17)
- Salvage transhepatic arterial embolization after failed stage I ALPPS in a patient with a huge HCC with chronic liver disease: A case report (2017) (16)
- Transcriptome integration analysis in hepatocellular carcinoma reveals discordant intronic miRNA-host gene pairs in expression (2017) (16)
- Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases (2009) (16)
- Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation (2011) (16)
- Changed clinical aspects of primary liver cancer in China during the past 30 years. (2004) (16)
- Reduction in p48-ISGFγ Levels Confers Resistance to Interferon-α2a in MHCC97 Cells (2005) (15)
- Surgical Treatment of Subclinical Cases of Hepatocellular Carcinoma (1987) (15)
- Atypical hepatic focal nodular hyperplasia presenting as acute abdomen and misdiagnosed as hepatocellular carcinoma (2007) (15)
- Down-regulation of β-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: a proteomic study (2007) (15)
- [Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma]. (2005) (15)
- Treatment of unresectable primary liver cancer: With reference to cytoreduction and sequential resection (2004) (15)
- A clinicopathological model to predict bone metastasis in hepatocellular carcinoma (2011) (15)
- Solitary minute hepatocellular carcinoma. A study of 14 patients (1991) (15)
- The potential of plasma thrombomodulin as a biomarker of portal vein tumor thrombus in hepatocellular carcinoma (2001) (15)
- [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection]. (2002) (15)
- CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway. (2014) (15)
- Herbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice (2010) (15)
- Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression (2011) (15)
- Impact factors for microinvasion in intrahepatic cholangiocarcinoma: a possible system for defining clinical target volume. (2010) (14)
- Direct Transformation of Lung Microenvironment by Interferon-α Treatment Counteracts Growth of Lung Metastasis of Hepatocellular Carcinoma (2013) (14)
- Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice (2004) (13)
- Hepatocellular carcinoma associated with tumor thrombosis in the portal vein: the effects of different treatments. (2003) (13)
- [Changes of clinical aspect of primary liver cancer in China during the past 30 years--control study for 3,250 cases with primary liver cancer]. (2003) (13)
- Clinical research of hepatocellular carcinoma in the 21st Century (1995) (13)
- Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA-in vitro and in vivo studies (2005) (13)
- Effects of cryopreservation and phenylacetate on biological characters of adherent LAK cells from patients with hepatocellular carcinoma. (2002) (12)
- Radioimmunotherapy for unresectable hepatocellular carcinoma using131I-Hepama-1 mAb: preliminary results (2005) (12)
- Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma (2010) (12)
- The value of postoperative hepatic regional chemotherapy in prevention of recurrence after radical resection of primary liver cancer. (2000) (12)
- Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization (2019) (12)
- [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma]. (2006) (12)
- Prediction of the Lymph Node Status in Patients with Intrahepatic Cholangiocarcinoma: Analysis of 320 Surgical Cases (2011) (12)
- Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma. (2003) (12)
- Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma (2012) (12)
- Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion (1992) (11)
- Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma. (2014) (11)
- [Nuclear accumulation of CXCR4 and overexpressions of VEGF-C and CK19 are associated with a higher risk of lymph node metastasis in hepatocellular carcinoma]. (2010) (11)
- Intrahepatic and intraperitoneal splenosis mimicking hepatocellular carcinoma with abdominal wall metastasis in a patient with hepatitis C cirrhotic liver. (2015) (10)
- Transcriptome and proteome of human hepatocellular carcinoma reveal shared metastatic pathways with significant genes (2015) (10)
- Results of liver resection for primary liver cancer (1994) (10)
- Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a (2018) (10)
- The targeted expression of the human interleukin-2/interferon α2b fused gene in α-fetoprotein-expressing hepatocellular carcinoma cells (1999) (10)
- Intrahepatic arterial I131 anti-hepatocellular carcinoma (HCC) monoclonal antibody combined with hepatic artery ligation for treatment of unresectable HCC (1993) (9)
- Relationship between expression of alpha-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma. (1999) (9)
- Recurrence after resection ofα-fetoprotein-positive hepatocellular carcinoma (2005) (9)
- Hepatocellular carcinoma with situs inversus totalis and polysplenia syndrome (2007) (9)
- Hepatocellular Carcinoma: The Role of Screening. (2000) (9)
- Efficacy of intra-hepatectomy 5-FU on recurrence and metastasis of human hepatocellular carcinoma in nude mice. (2001) (8)
- The abnormalities of chromosome 8 in two hepatocellular carcinoma cell clones with the same genetic background and different metastatic potential (2003) (8)
- Postoperative α-fetoprotein response predicts tumor recurrence and survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis. (2019) (8)
- Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma. (2003) (8)
- Multimodality treatment of hepatocellular carcinoma (1998) (7)
- Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype (2005) (7)
- Phase I Clinical Trial of Oral Furtulon and Combined Hepatic Arterial Chemoembolization and Radiotherapy in Unresectable Primary Liver Cancers, Including Clinicopathologic Study (2000) (7)
- Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis (2004) (7)
- Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries (2016) (6)
- Higher intratumor than peritumor expression of DUSP6/MKP‐3 is associated with recurrence after curative resection of hepatocellular carcinoma (2014) (6)
- Treatment of Hepatocellular Carcinoma (1998) (6)
- [Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma]. (2005) (6)
- [Loss of heterozygosity of plasma circulating DNA from hepatocellular carcinoma patients and its clinical significance]. (2007) (6)
- Advances in Brief The Association of Chromosome 8 p Deletion and Tumor Metastasis in Human Hepatocellular Carcinoma 1 (1999) (6)
- [Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials]. (2007) (6)
- The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma (2009) (5)
- Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy. (2019) (5)
- [The effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma]. (2005) (5)
- Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells. (2004) (5)
- Elevated MTSS 1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma (2016) (5)
- [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice]. (2006) (5)
- Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy. (2020) (5)
- Cryohepatectomy for hepatocellular carcinoma--results in 84 patients. (2002) (4)
- Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial131I-labeled Hepama-1 mAb. Preliminary results and discussion (1994) (4)
- Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma (2021) (4)
- [In-vivo targeted imaging of hepatocellular carcinoma in nude mice using quantum dot probes]. (2007) (4)
- 5-fluorouracil and hydroxyurea enhance adenovirus-mediated transgene expression in colon and hepatocellular carcinoma cells (2005) (4)
- Tumor radioimmunoimaging of chimeric antibody in nude mice with hepatoma xenograft. (1998) (4)
- Transcatheter arterial embolization-salvaged ALPPS, a novel ALPPS procedure especially for patients with hepatocellular carcinoma and severe fibrosis/cirrhosis (2021) (4)
- Simulation of portal/hepatic vein associated remnant liver ischemia/congestion by three-dimensional visualization technology based on preoperative CT scan (2021) (3)
- Primary clear cell carcinoma of the liver (2012) (3)
- The HBx protein expression in liver cancer (1993) (3)
- [Three-grade criteria of curative resection for primary liver cancer]. (2004) (3)
- Characteristics and prognosis of primary liver cancer in young patients in China (1995) (3)
- [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis]. (2004) (3)
- Long-Term Survival of Hepatocellular Carcinoma with Reference to the Role of Early Resection, Multioperation and Multimodality Treatment (1986) (3)
- [The prognostic significance of preoperative plasma level of osteopontin in combination with intercellular adhesion molecule-1 for patients with hepatocellular carcinoma]. (2005) (3)
- Liver transplantation: A simple inflammation marker predicts liver cancer prognosis (2011) (3)
- [Effects of MIM-B gene on invasive and metastatic potentials of human hepatocellular carcinoma MHCC97H cells]. (2010) (2)
- [Vasoinhibitory effect of daltepartin sodium on human hepatocellular carcinoma in nude mice]. (2005) (2)
- Long-term results of surgery for small primary liver cancer in 514 adults (2005) (2)
- Loss of Heterozygosity at D 8 S 298 Is a Predictor for Long-term Survival of Patients withTumor-Node-Metastasis Stage I of Hepatocellular Carcinoma (2007) (2)
- Abstract 3003: Immune cell-related microRNA-155 is associated with human liver cirrhosis and hepatocellular carcinoma (2010) (2)
- [Effects of the Chinese herbal extract Songyou Yin on the residual hepatocellular carcinoma after chemotherapy in nude mice]. (2013) (2)
- The microcell mediated transfer of human chromosome 8 into highly metastatic rat liver cancer cell line C5F. (2003) (2)
- Conversion of surgically verified unresectable to resectable hepatocellular carcinoma (1989) (2)
- [Immunoprotective effect of IL-2 and B7-1 gene co-transfected liver cancer vaccines on hepatocarcinogenesis in mice]. (2002) (2)
- Newsletter – Fall 1998 (1998) (2)
- [Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patient's peripheral blood monocytes (PBMC) pulsed with tumor antigen]. (2005) (2)
- Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration (2005) (2)
- [A preliminary study of the killing function in vitro by T lymphocytes activated by dendritic cells loaded with exosomes secreted by hepatic cancer cell lines with high or low metastatic potentials]. (2007) (2)
- Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma (2022) (2)
- [The value of CA19-9 in diagnosing hepatocellular carcinoma and intrahepatic cholangiocarcinoma]. (2006) (2)
- Study on the inhibitory effect of tyroserleutide on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis. (2007) (2)
- Metastasis-related genes in hepatocellular carcinoma cell-lines are clustered on chromosome territories predicted by transcriptome and proteome (2016) (2)
- [Diagnosis and management for early hepatic artery thrombosis after liver transplantation]. (2005) (2)
- Viral hepatitis (HBV and HCV) background in Chinese patients with hepatocellular carcinoma (1994) (2)
- Expert consensus on local ablation therapies for primary liver cancer. (2012) (2)
- mRNA levels of nm23 in murine ascites hepatoma (H22) clones with different lymphatic metastatic potential (2005) (2)
- [Primary experience of the anatomical laparoscopic left lateral hepatic lobectomy procedure for benign and malignant liver tumors]. (2008) (2)
- Treatment of hepatocellular carcinoma: A summary of 33 years' experience (1992) (2)
- Multiple Omics Integration Reveals Key Circular RNAs in Hepatocellular Carcinoma (2021) (2)
- Corrigendum to "Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma" [J Hepatol 67 (2017) 293-301]. (2017) (2)
- Nitric oxide synthase and vascular endothelial growth factor expression in hepatocellular carcinoma and the correlation with angiogenesis (2001) (2)
- Thirty years’ studies on surgery and related basic research of hepatocellular carcinoma (2003) (1)
- Missing-in-metastasis B (MIM-B) combined with caveolin-1 promotes metastasis of hepatocellular carcinoma (2017) (1)
- Multimodality treatment of hepatocellular carcinoma (1998) (1)
- [Diagnosis and treatment of primary hepatic carcinoid tumor]. (2007) (1)
- Metastasis of Hepatic Cancer (2012) (1)
- Modulation of gene expression in MHCC97 cells by interferon alpha. (2005) (1)
- [Comparison of the results and therapies for hepatocellular carcinoma with tumor thrombosis in portal vein]. (2003) (1)
- [Gene expression profile of human hepatocellular carcinoma cell lines with different metastatic potentials]. (2002) (1)
- Erratum to: Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma (2016) (1)
- [An in vitro research on interleukin-1 beta promoted invasiveness of human hepatocellular carcinoma MHCC97-H cells]. (2008) (1)
- [Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery]. (2006) (1)
- Reconstruction and expression of chimeric anti-HBx antibody inEscherichia coli (2005) (1)
- [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation]. (2004) (1)
- Hepatocellular carcinoma—challenge and prospect in the early 21st century (2004) (1)
- Multivariate analysis of risk factors of early and late recurrences after resection for primary clear cell carcinoma of liver (2012) (1)
- [Screening hepatocellular carcinoma autoantibodies by serological proteome analysis]. (2005) (1)
- Inhibitory effect of huaier on recurrent tumor growth following hepatic resection of hepatocellular carcinoma (2010) (1)
- Abstract 5086: The side effects of sorafenib in treating hepatocellular carcinoma. (2013) (1)
- [Cryohepatectomy for liver cancer: preliminary evaluation of reducing postoperative recurrence]. (2005) (1)
- [Screening low molecular weight protein biomarkers relevant to portal vein tumor thrombi in serum of patients with hepatocellular carcinoma]. (2007) (1)
- [Study on the relationship between serum cytokeratin 19 level in hepatocellular carcinoma patients and the clinico-pathologic characteristics]. (2004) (1)
- [Quantitative analysis of expression of TEY1 gene in liver cancer cells with different metastatic potential]. (2003) (1)
- Imaging , Diagnosis , Prognosis Gene Expression Profiling of Fixed Tissues Identified Hypoxia-Inducible Factor-1 a , VEGF , and Matrix Metalloproteinase-2 as Biomarkers of Lymph Node Metastasis in Hepatocellular Carcinoma (2011) (1)
- Tumor recurrence after liver transplantation for hepatocellular carcinoma: prevention and treatment (2011) (1)
- Considaration of the role of radiotherapy for intrahepatic cholangiocarcinoma? : A retrospective analysis of 145 patients (2006) (1)
- [Migration and invasion of human hepatocellular carcinoma mediated by lung extracts]. (2004) (1)
- [Osteopontin promotes the malignant phenotypes of human hepatocellular carcinoma cell line SMMC-7721]. (2007) (1)
- Associating liver partition and portal vien ligation for staged hepatectomy (2013) (1)
- [Effect of postoperative transcatheter arterial chemoembolization on hepatocellular carcinoma patients with residual tumor]. (2004) (1)
- Inhibitory effect of dalteparin sodium on the growth of early-stage hepatocellular carcinoma (2008) (1)
- Correction: MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma (2019) (1)
- [Therapeutic effectiveness of liver transplantation: a single center study of 203 consecutive cases]. (2005) (1)
- [Experimental observation on the alteration of metastatic potential and its gene function net of residual hepatocellular carcinoma following palliative liver resection]. (2010) (1)
- My View on the Biological Features and Surgical Treatment of Liver Cancer (2017) (1)
- Expression and purification of single-chain anti-HBx antibody in Escherichia coli (1997) (1)
- [Clinical research of hepatocellular carcinoma]. (2006) (1)
- [Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience]. (2006) (1)
- Gene expression in intrahepatic tumors through DNA recombination by a replication-activated adenovirus vector (2004) (1)
- Evaluation of Early Detection and Treatment of Hepatocellular Carcinoma (1993) (1)
- Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma (2017) (1)
- Abstract A21: Expression of placental growth factor in hepatocellular carcinoma and peritumoral liver and its prognostic significance (2010) (0)
- Factors influencing the effect of radioimmunotherapy on liver cancer (1992) (0)
- Human Cancer Biology Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial – Mesenchymal Transition (2011) (0)
- [Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma]. (2002) (0)
- The study of AGO1 regulates p53 expression and the prognosis of patients with hepatocellular carcinoma after curative resection (2014) (0)
- Abstract 1983: TP53 mutations in hepatocellular carcinoma: Association with survival and stem cell-like gene expression traits (2010) (0)
- [The level of transgelin related to the function of dendritic cells pulsed with liver cancer]. (2008) (0)
- [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft]. (2005) (0)
- Consideration of the Role of Radiotherapy for HCC With Portal Vein and/or Inferior Vena Cava Tumor Thrombus: A Retrospective Analysis of 217 Patients (2007) (0)
- ASO Visual Abstract: Hepatectomy Following Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy in Patients with Unresectable Hepatocellular Carcinoma (2023) (0)
- Strategies for management of unresectable cancer—Introduction (1995) (0)
- Microarray analysis of tyroservatide-regulated angiogenesis gene expression profile in human hepatocellular carcinoma cell SMMC-7721 (2008) (0)
- An approach improving long-term outcome of surgery for hepatocellular carcinoma: Analysis of 113 patients surviving more than five years (1992) (0)
- 1101 ANTI-ANGIOGENIC AGENTS MODULATED THE HOST BY SUPPRESSING IL-12b EXPRESSION AND PROMOTED LUNG METASTASIS IN EXPERIMENTAL HEPATOCELLULAR CARCINOMA (2013) (0)
- Circulating DNA level of hepatocellular carcinoma and its prognostic value (2006) (0)
- Subject Index Vol. 67, 2004 (2005) (0)
- Expression and prognostic value of sonic hedgehog in hepatocellular carcinoma (2011) (0)
- [Reconstructing the JAK/STATs signal pathway restored the anti-proliferative response of MHCC97 on interferon alpha]. (2006) (0)
- The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome (2011) (0)
- The predictive value of chromosome 8p deletion for metastasis of hepatocellular carcinoma: a summary of works in 10 years (2008) (0)
- [The relationship between lymphangiogenesis and lymphatic metastasis in murine hepatic carcinoma of high and low metastatic potentialities]. (2006) (0)
- Promoting invasive ability of hepatocellular carcinoma by co-culture of exosomes from tumor cells with high metastatic potential (2019) (0)
- Abstract A25: Array‐based comparative genomic hybridization of hepatocellular carcinoma reveals a unique genomic aberration pattern in tumors with poor prognosis (2009) (0)
- Changes of serum alpha fetoprotein before and after radioimmunotherapy in patients with hepatocellular carcinoma (1994) (0)
- Relationship between circRNA-100338/microRNA-141-3p axis and phosphatidylinositol 3 kinase/protein kinase B/mammalian target of rapamycin signaling pathway in hepatocellular carcinoma (2019) (0)
- [Molecular prediction of metastatic recurrence of hepatocellular carcinoma: from-omics to clinical application]. (2012) (0)
- Techniques of anatomical liver resection for hepatocellular carcinoma:a report of 125 cases (2010) (0)
- Genetically modified dendritic cells induced specific cytotoxity against human HCC cells in vitro (2004) (0)
- CISPLATIN ENHANCE THE ANTITUMOR EFFECT OF HSVTK/GC GENE THERAPY FOR HUMAN HEPATOCELLUALR CARCINONMA (1999) (0)
- [Relation between changes of dendritic cell function and down-regulation of beta-centractin in hepatocellular carcinoma]. (2007) (0)
- Effects of avastin combined with sorafenib in a highly metastatic murine model of human hepatocellular carcinoma (2010) (0)
- Strategies to improve the efficacy of liver transplantation for hepatocellular carcinoma (2011) (0)
- Effects of IFN-α on expression of angiogenic factors in highly metastatic human hepatocellular carcinoma cell line HCCLM3 cells (2004) (0)
- Results of treatment of primary liver cancer in China (1992) (0)
- [A clinicopathologic study of hepatic angiomyolipoma]. (2009) (0)
- Vasoinhibitory study of low molecular weight heparins in human hepatocellular carcinoma in nude mice (2004) (0)
- Free Paper Session II (2006) (0)
- Changes of PAI-1 in plasma and tumor extract of patients with hepatocellular carcinoma (1999) (0)
- Effects of interferon-alpha on thymidine phosphorylase expression and apoptosis in human hepatocellular carcinoma SMMC-7721 cells (2009) (0)
- Physical Activity Improves Outcomes of Combined Lenvatinib Plus Anti-PD-1 Therapy In Patients With Unresectable Hepatocellular Carcinoma (2021) (0)
- Molecular Events on Metastasis of Hepatocellular Carcinoma (2010) (0)
- Free Paper Session II (2006) (0)
- [Establishment of a high metastatic potential human hepatocellular carcinoma orthotopic transplantation model with palliative liver resection in nude mice]. (2013) (0)
- Interaction between missing in metastasis B and caveolin-1 in hepatocellular carcinoma (2017) (0)
- [Feasibility of using hepatitis B virus surface antigen as target antigen in immunogen therapy against cancer]. (2002) (0)
- The predictive values of combined assessment of preoperative plasma levels of OPN and ICAM-1 for prognosis of patients with hepatocellular carcinoma:retrospective and prospective validations (2006) (0)
- Abstract 4818: Validation and clinical utility of a human hepatocellular carcinoma metastasis signature as prognostic classifier (2010) (0)
- Re: Technique of Lateral Pancreaticojejunostomy (1998) (0)
- [Transcription factor activity profile of human hepatocellular carcinoma cell lines with different metastatic potentials]. (2006) (0)
- [Effects of high metastatic potential hepatocellular carcinoma cell-binding peptide on the invasion and metastasis of liver cancer]. (2009) (0)
- [Discussion on the road of liver cancer prevention and treatment in China]. (2015) (0)
- “Three-Grade Criteria” of radical resection for primary liver cancer (2005) (0)
- [Interferon-alpha upregulates thymidine phosphorylase expression via JAK-STAT transcriptional activation and mRNA stabilization in human hepatocellular carcinoma SMMC-7721 cells]. (2008) (0)
- [Influence of reconstruction of immunological functions of T lymphocytes on mouse hepatocarcinoma metastasis]. (2005) (0)
- Abstract 1556: A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma (2010) (0)
- The development and prospects of liver surgery (2023) (0)
- ̈ Three — Grade Criteria ̈ of RadicaI Resection for (0)
- Running title: Serum MDK in Diagnosis of HCC (2013) (0)
- [Study of serum proteome biomarkers with relation to the formation of portal vein tumor thrombi in hepatocellular carcinoma patients]. (2005) (0)
- Three Decades of Progress in Surgery for Primary Liver Cancer (1997) (0)
- Functional localization of metastasis suppressor genes for hepatocellular carcinoma on human chromosome 8p21.1-23.1 (2008) (0)
- The effect of phenylacetate on the expansion and cytotoxic activity of adherent lak cells from patients with hepatocellular carcinoma (2002) (0)
- Profiling changes in dendritic cells pulsed by hepatocellular carcinomas with different metastatic potentials (2009) (0)
- Abstract 4145: Increased anti-tumor effect of sorafenib by depleting tumor associated macrophages (2010) (0)
- Abstract LB-408: An integrative genomic approach uncovers oncogenic roles of YY1-signaling in hepatocellular carcinoma with stem cell-like traits (2012) (0)
- The roles of loss of heterozygosity at 8p22 in the molecular classification of patients with hepatocellular carcinoma, with special reference to survival after surgical operation (2006) (0)
- Important issues of cancer metastasis (2014) (0)
- [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection]. (2005) (0)
- [To explore a route to liver cancer research with Chinese features]. (2009) (0)
- Effects of exosomal circular RNA-100338 derived from hepatocellular carcinoma on angiogenesis of human umbilical vein endothelial cells (2020) (0)
- Molecular and Cellular Pathobiology A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients (2010) (0)
- P6-3 CLINICAL EXPERIENCE OF SURGERY FOR HEPATOCELLULAR CARCINOMA (1991) (0)
- Free Paper Session IV (2006) (0)
- The usefulness of99Tc-PMT delayed hepatobiliary imaging in the diagnosis of small hepatocellular carcinoma (1992) (0)
- Abstract 45: The clinical significance of CD163 in patients with hepatocellular carcinoma who underwent curative resection (2012) (0)
- [A clinicopathologic study of biliary intraductal papillary neoplasm]. (2010) (0)
- Hepatobiliary & Pancreatic Diseases International. (2017) (0)
- The role of TMPRSS4 in radiation induced metastasis of hepatocellular carcinoma (2011) (0)
- [Changes of metastatic potential of residual hepatocellular carcinoma in nude mice after in vivo chemotherapy and the corresponding mechanisms]. (2012) (0)
- Prognostic Subtypes of Hepatocellular Carcinoma-Fetoprotein Expression Defines Novel α EpCAM and Updated (2008) (0)
- [Interferon alpha enhances the sensitivity of SMMC-7721 hepatocellular carcinoma cells to 5'-deoxy-5-fluorouridine related to up-regulation of thymidine phosphorylase]. (2007) (0)
- [Key issues and prospects for the study on metastasis of hepatocellular carcinoma]. (2008) (0)
- [Functional localization of metastasis suppressor genes for HCC on human chromosome 8]. (2008) (0)
- Cancer Metastasis: Metastasis of Primary Liver Cancer (2011) (0)
- Using the miR-26 family as a predictive marker of hepatocellular carcinoma and sensitivity to therapy (2009) (0)
- Urokinase-type plasminogen activator, its receptor and inhibitor expression in hepatocellular carcinoma relation to cancer invasiveness and prognosis (1998) (0)
- Contents Vol. 67, 2004 (2005) (0)
- The mechanism of pseudomonasaeruginosa mannose sensitive hamemagglutination vaccine in inducing apoptosis of hepatocellular carcinoma (2011) (0)
- [The investigation of the technology of microcell mediated chromosome transfer for functional localization of metastasis suppressor genes for liver cancer on human chromosomes]. (2006) (0)
- [Segmentectomy for hepatoma originated from segment IX]. (2004) (0)
- Follow-up study in 20-year survivors after resection for hepatocellular carcinoma in 53 cases (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Zhao‐you Tang?
Zhao‐you Tang is affiliated with the following schools: